Tara Holguin
Physician Assistant · Orange, CANPI 1417491721
Payments from drug & device makers
Across 269 payments — averaging $20.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$784
- Novo Nordisk$694
- AbbVie$394
- Amgen$380
- Boehringer Ingelheim$266
- Abbott$261
- plus $3K from 26 others
What the payments were for
- Food & beverage$5,590100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 51 | $784 |
| Novo Nordisk | 35 | $694 |
| AbbVie | 17 | $394 |
| Amgen | 19 | $380 |
| Boehringer Ingelheim | 12 | $266 |
| Abbott | 10 | $261 |
| Sanofi-aventis U.S. LLC | 14 | $240 |
| Mannkind Corporation | 12 | $234 |
| Xeris Pharmaceuticals, Inc. | 11 | $227 |
| Medtronic | 12 | $226 |
| Insulet Corporation | 11 | $216 |
| Dexcom, Inc. | 8 | $178 |
| Cequr Corporation | 2 | $177 |
| Tandem Diabetes Care, Inc. | 7 | $173 |
| Bayer | 2 | $130 |
| Radius Health, Inc. | 5 | $130 |
| Corcept Therapeutics | 4 | $116 |
| Antares Pharma, Inc. | 6 | $114 |
| Embecta Corp. | 4 | $108 |
| Ascendis Pharma Endocrinology Inc | 4 | $96 |
| AstraZeneca(2 entities) | 4 | $93 |
| Recordati_rare_diseases_inc. | 3 | $76 |
| IBSA Pharma Inc. | 4 | $74 |
| Merck | 3 | $45 |
| BD | 2 | $41 |
| Sequel Med Tech, LLC | 1 | $23 |
| Acerus Pharmaceuticals Corporation | 1 | $22 |
| Halozyme Inc | 1 | $17 |
| Amryt Pharma Holdings Ltd | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Amphastar Pharmaceuticals, Inc. | 1 | $14 |
| Tolmar, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$121
- Kerendia$115
- CeQur Simplicity$107
How this compares
$5,590 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 164 | $239,295 |
| TrulicityDulaglutide | 40 | $59,581 |
| JardianceEmpagliflozin | 30 | $49,169 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 36 | $47,250 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 20 | $33,954 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 33 | $30,248 |
| FarxigaDapagliflozin Propanediol | 20 | $26,480 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 36 | $21,538 |
| MounjaroTirzepatide | 18 | $20,554 |
| SynjardyEmpagliflozin/Metformin Hcl | 13 | $16,709 |
| Tresiba Flextouch U-100Insulin Degludec | 27 | $13,189 |
| TradjentaLinagliptin | 13 | $11,461 |
| Repatha SureclickEvolocumab | 11 | $8,232 |
| Tresiba Flextouch U-200Insulin Degludec | 12 | $7,804 |
| Humalog Kwikpen U-100Insulin Lispro | 22 | $5,615 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $694 | $239,295164 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Trijardy Xr, Synjardy, Tradjenta | $266 | $158,543112 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $784 | $80,13558 claims |
| AstraZenecaFarxiga | $93 | $26,48020 claims |
| AbbVieSynthroid | $394 | $4,23335 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Orange
- Nina LuongOrange$78K
- Janette VillalonOrange$35K
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.